Coronary slow flow (CSF) is an angiographic phenomenon with specific epidemiologic
characteristics, associated clinical presentation, and prognosis. Although patients with CSF …

The coronary slow flow phenomenon (CSFP) is an important, angiographic entity
characterized by delayed progression of the injected contrast medium through the coronary …

Endothelium plays a crucial role in the maintenance of vascular tone and structure.
Endothelial dysfunction is known to precede overt coronary artery disease. A number of …

Background and purpose Endothelial dysfunction may play a role in the pathogenesis of the
slow coronary flow (SCF) phenomenon. A detailed examination of blood cellular …

Background Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of endothelial
nitric oxide synthase by competing with L-arginine. As a result, the expression of nitric oxide …

Background The coronary slow flow phenomenon (CSFP) is an angiographic finding
characterized by delayed distal vessel opacification in the absence of significant epicardial …

The coronary slow flow phenomenon (CSFP) is associated with coronary microvascular
dysfunction although the responsible mechanisms are unknown. This study compared …

Coronary slow flow phenomenon (CSFP) is an important, angiographic entity characterized
by delayed progression of the contrast medium injected into the coronary tree. Since …

The coronary slow flow phenomenon (CSFP) is a disease entity characterized by slow
progression of angiographic contrast in the coronary arteries in the absence of stenosis in …

Coronary microvascular dysfunction is an underdiagnosed pathologic process that is
associated with adverse clinical outcomes. Biomarkers, molecules measurable in the blood …